Chest Care by Dr Saima Jatoi

Pneumonia occurring before or within 48 hours of hospital admission.

Common Organisms

• Streptococcus pneumoniae (most common)
• Haemophilus influenzae
• Staphylococcus aureus
• Moraxella catarrhalis
• Mycoplasma pneumoniae
• Respiratory viruses (Influenza virus, RSV)

---

# # Hospital-Acquired Pneumonia (HAP)

Definition

Pneumonia developing 48 hours or more after hospital admission and was not incubating at the time of admission.

Common Organisms

• Staphylococcus aureus (including MRSA)
• Pseudomonas aeruginosa
• Klebsiella pneumoniae
• Escherichia coli
• Acinetobacter species

---

# # Streptococcus pneumoniae

• Most common cause of community-acquired pneumonia.
• Gram-positive lancet-shaped diplococci.
• Produces rust-colored sputum.
• Common in elderly, alcoholics, post-splenectomy patients, immunocompromised patients, and those with chronic heart or lung disease.
• May cause bacteremia, meningitis, empyema, and pleural effusion.

---

# # Staphylococcus aureus

• Gram-positive cocci in clusters.
• Most common cause of secondary bacterial pneumonia following influenza.
• Seen in intravenous drug users, diabetics, cystic fibrosis patients, and immunocompromised individuals.
• Causes lung abscess, cavitary pneumonia, empyema, and pneumatoceles.

---

# # Klebsiella pneumoniae

• Gram-negative encapsulated bacillus.
• Common in alcoholics, diabetics, elderly, and debilitated patients.
• Produces thick red currant-jelly sputum.
• Causes severe necrotizing pneumonia with upper lobe cavitation.
• Frequently multidrug resistant.

---

# # Pseudomonas aeruginosa

• Gram-negative rod.
• Produces green sputum due to pyocyanin pigment.
• Important cause of hospital-acquired pneumonia.
• Most common pathogen in cystic fibrosis.
• Common in bronchiectasis, ventilated patients, and immunocompromised individuals.
• Causes severe necrotizing pneumonia with high mortality.

---

# # Mycoplasma pneumoniae

• Smallest free-living bacterium.
• Has no cell wall; therefore penicillins and cephalosporins are ineffective.
• Causes atypical pneumonia.
• Presents with fever, headache, malaise, myalgia, sore throat, and dry cough.
• Diagnosis is by PCR or serology.
• Cold agglutinins may cause autoimmune hemolytic anemia.
• Associated with erythema multiforme, Stevens–Johnson syndrome, Guillain–Barré syndrome, encephalitis, and myocarditis.

---

# # Legionella pneumophila

• Found in contaminated water systems, cooling towers, air-conditioning systems, and hot water tanks.
• Causes Legionnaires' disease.
• Presents with high fever, dry cough, dyspnea, myalgia, and headache.
• Extrapulmonary manifestations include diarrhea, abdominal pain, confusion, and neurological symptoms.
• Laboratory findings include hyponatremia and elevated liver enzymes.
• Diagnosis is by urinary antigen test, culture on BCYE agar, or PCR.
• Treatment is azithromycin or levofloxacin.

---

# # Haemophilus influenzae

• Gram-negative coccobacillus.
• Common in smokers and patients with COPD.
• Important bacterial cause of acute exacerbation of COPD.
• Most common organism isolated in non-cystic fibrosis bronchiectasis.
• May cause otitis media, sinusitis, epiglottitis, and pneumonia.

---

# # High-Yield IMM/FCPS Pearls

• Most common cause of community-acquired pneumonia: Streptococcus pneumoniae.
• Most common bacterial pneumonia after influenza: Staphylococcus aureus.
• Rust-colored sputum: Streptococcus pneumoniae.
• Currant-jelly sputum: Klebsiella pneumoniae.
• Green sputum: Pseudomonas aeruginosa.
• No cell wall: Mycoplasma pneumoniae.
• Air conditioner-associated pneumonia: Legionella pneumophila.
• Pneumonia with hyponatremia: Legionella pneumophila.
• Common bacterial cause of acute exacerbation of COPD: Haemophilus influenzae.
• Most common pathogen in cystic fibrosis: Pseudomonas aeruginosa.
• Most common organism isolated in non-cystic fibrosis bronchiectasis: Haemophilus influenzae.
• Pneumonia with upper lobe cavitation in alcoholics: Klebsiella pneumoniae.

Bulla

A bulla is an air-filled space within the lung parenchyma measuring more than 1 cm in diameter, resulting from destruction of alveolar walls. The wall is formed by attenuated alveolar septa and compressed lung tissue and is usually less than 1 mm thick.

Cavity

A cavity is a gas-filled space within an area of pulmonary consolidation, mass, or nodule that develops after necrosis and drainage of necrotic material through the bronchial tree.

---

Pathophysiology

# # # Bulla

• Destruction of alveolar septa
• Coalescence of adjacent air spaces
• Loss of pulmonary capillary bed
• Air trapping with hyperinflation
• No tissue necrosis

# # # Cavity

• Pulmonary tissue necrosis
• Liquefaction of lung parenchyma
• Communication with the bronchial tree
• Drainage of necrotic material leaving an air-filled space

---

CT Features

Bulla

• Very thin or imperceptible wall
• Near-air attenuation (approximately −900 to −1000 HU)
• No surrounding consolidation
• Adjacent compressed lung
• Frequently associated with emphysema

Cavity

• Thick irregular wall
• Irregular inner margin
• Air, fluid, debris or fungal ball may be present
• Surrounding consolidation or fibrosis
• Satellite nodules or tree-in-bud pattern may coexist

---

# # Wall Thickness Rule

4 mm → More likely to represent a cavity

> 15 mm → Highly suspicious for malignancy

Wall thickness should always be interpreted together with the clinical picture and CT findings.

---

# # Air-Fluid Level

# # # Bulla

Usually absent.

If present, consider:
• Secondary infection
• Hemorrhage
• Bronchopleural fistula

# # # Cavity

Frequently seen in:
• Lung abscess
• Pulmonary tuberculosis
• Necrotizing pneumonia
• Cavitating malignancy
• Fungal infections

---

# # Common Causes

# # # Bullae

• Smoking-related emphysema (COPD)
• Alpha-1 antitrypsin deficiency
• Giant bullous disease (Vanishing Lung Syndrome)
• Marfan syndrome
• Ehlers-Danlos syndrome
• HIV-associated emphysema

# # # Cavities

Infectious
• Tuberculosis
• Lung abscess
• Necrotizing bacterial pneumonia
• Aspergillosis
• Histoplasmosis
• Nocardiosis
• Septic emboli

Neoplastic
• Squamous cell carcinoma
• Cavitating metastases

Inflammatory
• Granulomatosis with polyangiitis
• Rheumatoid nodules

Vascular
• Pulmonary infarction

Congenital (rare)
• Infected congenital pulmonary airway malformation

---

# # Clinical Features

# # # Bulla

• Progressive dyspnea
• COPD symptoms
• Reduced breath sounds
• Hyperinflation
• Spontaneous pneumothorax

# # # Cavity

• Fever
• Productive cough
• Weight loss
• Hemoptysis
• Night sweats
• Chest pain

---

# # Complications

# # # Bullae

• Spontaneous pneumothorax
• Infection
• Compression of adjacent lung
• Respiratory failure

# # # Cavities

• Massive hemoptysis
• Bronchopleural fistula
• Empyema
• Aspergilloma
• Persistent infection

---

# # Giant Bulla vs Pneumothorax

# # # Giant Bulla

• Thin curvilinear wall
• No vascular markings only within the bulla
• Compressed lung visible beyond the wall
• No visceral pleural line

# # # Pneumothorax

• Distinct visceral pleural line
• No vascular markings peripheral to the pleural line
• Collapsed lung medially
• Free pleural air

Mistaking a giant bulla for a pneumothorax may lead to inappropriate chest tube insertion.

---

# # Differential Diagnosis

| Lesion | Characteristic Feature |
| -------------- | ----------------------------------------------- |
| Bulla | Thin wall (

Mechanical ventilation is indicated when a patient is unable to maintain adequate oxygenation, ventilation, or airway protection despite optimal medical management. The decision to intubate should be based on the overall clinical condition, not on arterial blood gas (ABG) values alone.

Major Indications

1. Refractory Hypoxemia

Persistent hypoxemia despite adequate oxygen therapy is a common indication for invasive mechanical ventilation. It is typically characterized by:
• PaO₂

A pigtail chest catheter is a small-bore (8–14 Fr) flexible drainage catheter with a curled ("pigtail") tip designed to drain air or fluid from the pleural cavity. It is usually inserted under ultrasound guidance for pleural effusions and ultrasound or CT guidance when appropriate.

# # Indications

A pigtail catheter is indicated for:

* Pleural effusion (transudative or exudative)
* Malignant pleural effusion
* Empyema (early or loculated when appropriate)
* Pneumothorax (primary or secondary)
* Hemothorax (selected stable patients with small-volume collections)

Not ideal for:

* Massive hemothorax requiring rapid drainage (large-bore chest tube preferred)
* Thick organized empyema where surgery may be required

# # Advantages

* Less painful than large-bore chest tubes
* Smaller incision
* Better patient comfort
* Lower complication rate
* Can be inserted under local anesthesia
* Suitable for bedside ultrasound-guided insertion

# # Daily Care

Monitor the patient and drainage system for:

* Respiratory status
* Oxygen saturation
* Drainage volume
* Drainage color and consistency
* Presence of air leak (bubbling)
* Tube patency
* Dressing integrity
* Signs of infection
* Tube position
* Chest X-ray when clinically indicated

Keep the drainage bottle below chest level and avoid kinking of the tubing.

# # Drainage Principles

# # # Pleural Effusion

Current guidelines recommend:

* Drain slowly.
* Generally avoid removing more than 1–1.5 L during a single drainage session, especially in chronic large effusions.
* Stop drainage if the patient develops:

* Chest pain
* Persistent cough
* Dyspnea
* Hypotension
* Vasovagal symptoms

The aim is to reduce the risk of re-expansion pulmonary edema, although this complication is uncommon.

# # # Pneumothorax

* Connect to an underwater seal drainage system.
* Do not routinely clamp while an air leak persists.
* Suction is used only if indicated.
* Tube removal is considered after lung re-expansion and cessation of air leak.

# # Clamping

Clamping is generally not recommended in:

* Active pneumothorax
* Persistent air leak
* Mechanically ventilated patients with ongoing air leak

Clamping may be considered:

* Before drain removal in selected patients after the air leak has resolved (institutional practice varies)
* During intermittent drainage of malignant pleural effusion if clinically indicated

Routine clamping after exactly 500 mL drainage is not supported by current guidelines.

# # Removal Criteria

The catheter can usually be removed when:

* Lung is fully expanded on chest X-ray
* No air leak is present
* Drainage is typically less than 150–200 mL/day (depending on the clinical situation)
* Patient is clinically improving

# # Removal Technique

1. Explain the procedure.
2. Remove sutures.
3. Ask the patient to perform a Valsalva maneuver or hold their breath at end-expiration.
4. Remove the catheter in one smooth motion.
5. Immediately apply an occlusive airtight dressing.
6. Observe the patient for respiratory symptoms.
7. Obtain a chest X-ray if clinically indicated. Many centers perform one within 4–6 hours, while others reserve imaging for symptomatic patients.

# # Complications

Early:

* Bleeding
* Pain
* Vasovagal reaction
* Organ injury (rare)
* Pneumothorax after insertion

Late:

* Infection
* Tube blockage
* Tube dislodgement
* Persistent air leak
* Subcutaneous emphysema
* Re-expansion pulmonary edema (rare)
* Catheter kinking

# # Key Clinical Pearls

* Ultrasound guidance is recommended for pleural effusions and significantly reduces complications.
* Small-bore (8–14 Fr) catheters are effective for most pleural effusions and many pneumothoraces.
* Do not routinely clamp a drain with an active air leak.
* Avoid rapid drainage of large chronic effusions; monitor the patient rather than relying on a strict volume cutoff.
* Always interpret drainage volume alongside the patient's symptoms and radiological findings.